Page last updated: 2024-09-03

omega-n-methylarginine and harmaline

omega-n-methylarginine has been researched along with harmaline in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(harmaline)
Trials
(harmaline)
Recent Studies (post-2010) (harmaline)
4,4113443366332125

Protein Interaction Comparison

ProteinTaxonomyomega-n-methylarginine (IC50)harmaline (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)4.9
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)0.012
Amine oxidase [flavin-containing] AHomo sapiens (human)0.0329

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cler, J; Emmett, MR; Iyengar, S; Mick, S; Rao, TS; Wood, PL1

Other Studies

1 other study(ies) available for omega-n-methylarginine and harmaline

ArticleYear
Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqualate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo.
    Journal of neurochemistry, 1990, Volume: 55, Issue:1

    Topics: Alkaloids; Amino Acid Oxidoreductases; Amino Acids; Animals; Arginine; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Harmaline; Male; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; omega-N-Methylarginine; Pentylenetetrazole; Receptors, Amino Acid; Receptors, Cell Surface

1990